Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3566-3570

  Gottlob, Katrin ^a   Pagano, Sabrina ^b   Levrero, Massimo ^b,c   Graessmann, Adolf ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HEPATITIS B VIRUS; LIVER CARCINOGENESIS; LIVER CARCINOMA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSACTIVATION; VIRUS GENE; VIRUS MUTANT;

ANTIGENS, VIRAL, TUMOR; CELL TRANSFORMATION, VIRAL; HEPATITIS B VIRUS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; VIRAL PROTEINS;

EID: 0032529463     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ganem, D., and Varmus, H. E. The molecular biology of hepatitis B viruses. Annu. Rev. Biochem., 56: 651-693, 1987.
2. Yen, T. S. B. J. Hepadnaviral X protein: review of recent progress. Biomed. Sci., 3: 20-30, 1996.
3. Zoulim, F., Saputelli, J., and Seeger, C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol., 68: 2026-2030, 1994.
4. Hohne, M., Schaefer, S., Seifer, M., Feitelson, M. A., Paul, D., and Gerlich, W. H. Malignant transformation of immortalized transgenic hepatocytes after transfection of hepatitis B virus DNA. EMBO J., 9: 1137-1145, 1990.
5. Kim, C. M., Koike, K., Saito, I., Miyamura, T., and Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (Lond.), 353: 317-320, 1991.
6. Billet, O., Grimber, G., Levrero, M., Seye, K. A., Briand, P., and Joulin, V. In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J. Virol., 69: 5912-5916, 1995.
7. Dragani, T. A., Manenti, G., Farza, H., Della Porta, G., Tiollais, P., and Pourcel, C. Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis. Carcinogenesis (Lond.), 11: 953-9956, 1989.
8. Lee, T. H., Finegold, M. F., Shen, R-F., DeMayo, J. L., Woo, S. L. C., and Butel, J. S. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J. Virol., 64: 5939-5947, 1990.
9. Slagle, B. L., Lee, T. H., Medina, D., Finegold, M. J., and Butel, J. S. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinog., 15: 261-269, 1996.
10. Terradillos, O., Billet, O., Renard, C-A., Levy, R., Molina, T., Briand, P., and Buendia, M. A. The hepatitis B virus X gene potentiates c-myc induced liver oncogenesis in transgenic mice. Oncogene, 14: 395-404, 1997.
11. Dandri, M., Schirmaker, P., and Rogler, C. E. Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and Woodchuck hepatocellular carcinomas which are permissive for viral replication. J. Virol., 70: 5246-5254, 1996.
12. Benn, J., and Schneider, R. J. Hepatitis B virus HBx activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc. Natl. Acad. Sci. USA, 91: 10350-10354, 1994.
13. Natoli, G., Avantaggiati, M. L., Chirillo, P., Puri, P. L., Ianni, A., Balsano, C., and Levrero, M. Ras-and Raf-dependent activation of c-Jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene, 9: 2837-2843, 1994.
14. Cross, J. C., Wen, P., and Rutter, W. J. Transactivation by hepatitis B virus X protein is promiscous and dependent on mitogen-activated cellular serine/threonine kinases. Proc. Natl. Acad. Sci. USA, 90: 8078-8082, 1993.
15. Benn, J., Su, F., Doria, M., and Schneider, R. J. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J. Virol., 70: 4978-4985, 1996.
16. Su, F., and Schneider, R. J. Hepatitis B virus HBx activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J. Virol., 70: 4558-4566, 1996.
17. Chirillo, P., Falco, M., Puri, P. L., Artini, M., Balsano, C., Levrero, M., and Natoli, G. Hepatitis B virus pX activates NFκB dependent transcription through a Raf-independent pathway. J. Virol., 70: 254-291, 1996.
18. Benn, J., and Schneider, R. J. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad. Sci. USA, 92: 11215-11219, 1995.
19. Chirillo, P., Natoli, G., Puri, P. L., Burgio, V. L., Balsano, C., and Levrero, M. The hepatitis B virus pX protein induces p53 mediated programmed cell death. Proc. Natl. Acad. Sci. USA, 94: 8162-8167, 1997.
20. Su, F., and Schneider, R. J. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor-α. Proc. Natl. Acad. Sci. USA, 94: 8744-8749, 1997.
21. Wang, X. W., Gibson, M. K., Vermeulen, W., Yeh, H., Forrester, K., Sturzbecher, H. W., Hoeijmakers, J. H. J., and Harris, C. C. Abrogation of p53 induced apoptosis by the hepatitis B virus X gene. Cancer Res., 55: 6012-6016, 1995.
22. Elmore, L. W., Hancock, A. R., Chang, S-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., and Harris, C. H. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc. Natl. Acad. Sci. USA, 94: 14707-147128, 1997.
23. Williams, J. S., and Andrisani, O. M. The hepatitis B virus X protein targets the basic region-leucin zipper domain of CREB. Proc. Natl. Acad. Sci. USA, 92: 3819-3823, 1995.
24. Takada S., Kido, H., Fukutomi, A., Takeshi, M., and Koike, K. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor. Oncogene, 9: 341-348, 1994.
25. Feitelson, M. A., Zhu, M., Duan, L. X., and London, W. T. Hepatitis B virus X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene, 8: 1109-1117, 1993.
26. Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J-R., and Harris, C. C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding transcriptional activity and association with transcription factor ERCC-3. Proc. Natl. Acad. Sci. USA, 91: 2230-2234, 1994.
27. Truant, R., Antunovic, J., Greenblatt, J., Prives, C., and Cromlish, J. A. Direct association of the hepatitis B virus HBx protein with the p53 leads to inhibition by HBx of p53 response element-directed transactivation. J. Virol., 69: 1851-1859, 1995.
28. Quadri, I., Maguire, H. F., and Siddiqui, A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc. Natl. Acad. Sci. USA, 92: 1003-1007, 1995.
29. Cheong, H-S., Yi, M-K., Lin, Y., and Murakami, S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J., 14: 143-150, 1995.
30. Fisher, M., Runkel, L., and Schaller, H. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome α-subunit. Virus Genes, 10: 99-102, 1995.
31. Huang, J., Kwong, J., Sun, E. C-Y., and Liang, T. J. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J. Virol., 70: 5582-5591, 1996.
32. Meyer, B. K., Pray-Gant, M. G., Vanden Heuvel, J. P., and Perdew, G. H. Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol. Cell. Biol., 18: 978-988, 1998.
33. Kuzhandaivelu, N., Cong, Y. S., Inouye, C., Yang, W. M., and Seto, E. XAP-2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res., 24: 4741-4750, 1996.
34. Murakami, S., Cheong, J-H., and Kaneko, S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J. Biol. Chem., 269: 15118-15123, 1994.
35. Runkel, L., Fisher, M., and Schaller, H. Two-codon insertion mutants of the HBx define two separate regions necessary for its transactivation function. Virology, 197: 529-536, 1993.
36. Bauer, M., Guhl, E., Graessmann, M., and Graessmann, A. Cellular mutation mediates T-antigen-positive revertant cells resistant to simian virus 40 transformation but not to transformation by polyomavirus and adenovirus type 2. J. Virol., 61: 1821-1827, 1987.
37. Graessmann, M., and Graessmann, A. Microinjection of tissue culture cells. Methods Enzymol., 101: 482-492, 1983.
38. Seto, E., and Yen, T. S. Mutual functional antagonism of the simian virus 40 T antigen and the hepatitis B virus transactivator. J. Virol., 65: 2351-2356, 1991.
39. Deppert, W., Kurth, M., Graessmann, M., Graessmann, A., and Knippschild, U. Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cells. Oncogene, 6: 1931-1838, 1991.
40. Avantaggiati, M. L., Carbone, M., Graessmann, A., Howard, B., and Levine, A. S. The SV40 large T-antigen and adenovirus Ela oncoproteins interact with different isoforms of the transcriptional coactivator, p300. EMBO J., 15: 2236-2248, 1996.